Nasal Spray Flu Vaccine Not Recommended for Upcoming Flu Season
The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) voted that the live attenuated influenza vaccine (LAIV), also known as the nasal spray flu vaccine, should not be used during the upcoming 2016-2017 flu season.
However, ACIP continues to recommend annual flu vaccination with either the inactivated influenza vaccine (IIV) or recombinant influenza vaccine (RIV) for everyone 6 months of age and older.
Why Did ACIP Vote This Way?
The ACIP vote is based on data that showed poor or relatively lower effectiveness of LAIV from 2013 through 2016. LAIV, which is sold as FluMist Quadrivalent, is currently the only non-injection-based flu vaccine available on the market.
How Do I Spread the Word to Patients?
To help start conversations with patients, the AAAAI has a new article describing that while the nasal spray influenza vaccine is not recommended for the upcoming flu season, they still need their flu shot. Access the article in English and Spanish using the links below. You are invited to share the links directly with patients or on your social media.
- Joint Congress Updates: Keynote Speaker Announced, Abstract and Case Report Submissions Due August 31
- Want Extra Help Getting to Orlando?
- Make an Impact, Join a Committee
- Enticing the Next Generation of Allergist/Immunologists
- New! The Practice Management Workshop Now Online
- Save the Date: JACI: In Practice Virtual Journal Club Webinar on September 14
- Educate Patients During Our Back-to-School Twitter Chat
- It’s Been a Busy Summer for the AAAAI Foundation
- Apply for Research Awards
- View Sessions from the 2017 Annual Meeting
- Check Out the Latest Opportunities in the Career Connections Center